Intraocular pressure control after contact transscleral diode cyclophotocoagulation in eyes with intractable XXXX .

@entity1 @entity1018 @entity726 @entity2687 @entity2297
PURPOSE: The effect of contact transscleral diode cyclophotocoagulation (TDC) on intraocular pressure (IOP) and its safety was determined in eyes with intractable @entity726 . METHODS: The charts of 41 consecutive @entity1 (43 eyes) who underwent the laser procedure were reviewed. After surgery, data were collected from chart entries at I hour, 1 day, 4 to 6 weeks, 4 to 6 months, and at the final visit (6-24 months). Mean differences in IOP before and after treatment were compared using the paired Student t test. Associated complications also were assessed. RESULTS: The mean +/- standard deviation follow-up period was 11.9+/-5.3 months (range, 6-24 months). One @entity1 who died after 1 month of follow-up and another @entity1 with @entity2297 who underwent an anterior chamber washout 1 week after laser to treat an uncontrolled IOP spike were excluded from the study. Repeat treatment was done in 12 (28%) eyes. At each follow-up visit postoperatively, a significant reduction from preoperative IOP was obtained (mean reduction of 50% at the final visit). At the final visit, 64% of @entity1 achieved an IOP of <22 mmHg and a reduction of > or =20%. An IOP spike occurred in three (7%) eyes. Long-term complications included @entity1018 (> or =2 lines) in eight (22%) @entity1 , @entity2687 in one (2%), phthisis bulbi in one (2%), and corneal graft rejection in one (2%). CONCLUSION: Although effective IOP reduction was demonstrated in eyes with intractable @entity726 after TDC, a significant proportion (26%) of eyes had severe long-term complications.
